Ed and Ethel Moore Alzheimer’s Disease Research Program
Florida Department of Health
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Feb 13, 2026
- Closes
- Oct 20, 2026
- Last verified
- Sep 7, 2026
Similar opportunities open now
- Rare Pediatric Diseases Research Grant ProgramSame funderOpenFlorida Department of HealthCloses Oct 26, 2026
- Florida Cancer Innovation FundSame funderOpenFlorida Department of HealthCloses Nov 7, 2026 (in 21 days)
- Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)OpenNational Institutes of HealthCloses Nov 2027Up to $1.5M
- Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses May 2028Up to $1M
- Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)OpenNational Institutes of HealthCloses Nov 19, 2026 (in 33 days)
Amount
Amount not listed here. Check the official program.
Who can apply
6.1. Applicants According to sections 215.5602(5)(a) and 381.922(3)(a), Florida Statutes, applications for biomedical research funding may be submitted by any Florida-based universities or established research institutes. Additionally, to be considered eligible, all the following guidelines must be met. Grant applications failing to meet the eligibility requirements will be rejected. 1. All grant-funded activities must take place in Florida. All work (effort) must occur, and funds must be spent in Florida by the applicant and any collaborators or consortium partners. However, the Department may make exceptions if the service is essential and only provided outside Florida, and if the amount is less than 10% of the total award. 2. Subcontracts must be described in the Biomedical Research Sec...
About this opportunity
Ed and Ethel Moore Alzheimer’s Disease Research Program Grants to encourage novel studies that can lead to advances in care prevention, diagnosis, treatment, care management, therapeutic approaches, and cure of Alzheimer’s disease.